Skip to main content
. 2021 Mar 7;9(3):266. doi: 10.3390/biomedicines9030266

Table 1.

Subject demographics and clinical data collected.

Number of Subjects Healthy Controls AAc LPP FFA
n = 12 % n = 7 % n = 6 % n = 6 %
Male 6 50 0 0 0 0 0 0
Female 6 50 7 100 6 100 6 100
Mean age, years (SD) 28.7 (7.2) 41.3 (15.9) 54.8 (18.1) 56.8 (7.4)
Mean Weight, kg (SD) 67.1 (10.8) 70 (6.5) 62.7 (17.8) 71.8 (7.7)
Mean Height, cm (SD) 170.8 (10.2) 171.4 (4.2) 166 (6.4) 167.4 (7.1)
Atopic Dermatitis 0 0 0 0
Psoriasis 0 0 0 0
Fitzpatrick Phototype
Type II 5 42% 2 29% 1 17% 1 17
Type II/III 0 0% 0 0% 1 17% 1 17
Type III 3 25% 3 43% 4 67% 1 33
Type III/IV 0 0% 2 29% 0 0% 0 0
Type IV 3 25% 0 0% 0 0% 2 33
Type V 1 8% 0 0% 0 0% 0 0
Scalp pH (SD)
Frontal 6 (1.5) n/a n/a n/a
Occipital 5.7 (1.2) n/a n/a n/a
Affected n/a 6.9 (1.1) 6.8 (0.8) 6.5 (0.8)
Not Affected n/a 6.9 (2) 6.9 (1.3) 6.3 (0.6)
Scalp Sebum (SD)
Frontal 107.4 (96.5) n/a n/a n/a
Occipital 78.8 (73.6) n/a n/a n/a
Affected n/a 44.3 (49.5) 71.3 (65.9) 29 (39.1)
Not Affected n/a 16.1 (14.5) 60.2 (20.1) 41 (37.9)
DLQI (mean, SD) n/a 5 (3.8) 5.8 (2.1) 4.2 (3.7)
Severity Score1 (mean, SD) n/a 20.3 (15.2) 6.6 (2.4) 33.9 (6.2)